课题基金 / 基金详情

Combination chemoprevention of hepatocellular carcinoma with acyclic retinoid by targeting RXRαphosphorylation

Combination chemoprevention of hepatocellular carcinoma with acyclic retinoid by targeting RXRαphosphorylation
靶向 RXRα 磷酸化的无环维A酸联合化学预防肝细胞癌
批准号:
21590838
负责人:
MORIWAKI Hisataka
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

MORIWAKI Hisataka的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acyclic retinoid, a synthetic retinoid targeting RXR., prevented the recurrence of hepatocellular carcinoma(HCC) in hepatitis C virus-positive patients in a phase II/III clinical trial. This agent also inhibits obesity-related liver tumorigenesis and acts synergistically with valproic acid, GW4064, a FXR ligand, and branched-chain amino acids in suppressing growth in human HCC cells, indicating that "combination chemoprevention" with acyclic retinoid as the key drug has great potential to become an effective strategy for the prevention of liver carcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00432-010-0938-0
发表时间: 2011-05
期刊: Journal of Cancer Research and Clinical Oncology
影响因子: 3.6
作者: [J. Kitagawa;T. Hara;H. Tsurumi;Soranobu Ninomiya;Kengo Ogawa;Seiji Adachi;N. Kanemura;S. Kasahara;M. Shimizu;H. Moriwaki]
通讯作者: J. Kitagawa;T. Hara;H. Tsurumi;Soranobu Ninomiya;Kengo Ogawa;Seiji Adachi;N. Kanemura;S. Kasahara;M. Shimizu;H. Moriwaki
Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
IDO 能够减轻 α-半乳糖神经酰胺诱导的肝炎模型中的肝损伤。
DOI: --
发表时间: 2010
期刊: J Immunol. 185
影响因子: --
作者: [Ito, H., Hoshi, M., Ohtaki, H., Taguchi, A., Ando, K., Ishikawa, T., Osawa, Y., Hara, A., Moriwaki, H., Saito, K., Seishima, M.]
通讯作者: M.
DOI: 10.1038/labinvest.2009.110
发表时间: 2010-01-01
期刊: LABORATORY INVESTIGATION
影响因子: 5
作者: [Komi, Yusuke, Sogabe, Yukihisa, Kojima, Soichi]
通讯作者: Kojima, Soichi
DOI: 10.1016/j.bbrc.2011.05.115
发表时间: 2011-06-24
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Kubota, Masaya, Shimizu, Masahito, Moriwaki, Hisataka]
通讯作者: Moriwaki, Hisataka
51
    Strategy for chemoprevention of digestive cancers by targeting abnormalities in receptor tyrosine kinases and nuclear receptors
    • 批准号:
      19590720
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      MORIWAKI Hisataka
    • 依托单位:
    Strategy for the chemoprevention of hepatocellular carcinoma by targeting phosphorylated RXRa
    • 批准号:
      17015016
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $50.88万
    • 财政年份:
      2005
    • 负责人:
      MORIWAKI Hisataka
    • 依托单位:
    The role of cytokine cascade in impaired liver regeneration and development of candidate pharmaceutical(s) to regulate this mechanism
    • 批准号:
      16590585
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2004
    • 负责人:
      MORIWAKI Hisataka
    • 依托单位:
    Retinoid upregulates the sensitivity of cancer cells to a cytokine by inducing the cytokine receptor
    • 批准号:
      13557048
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.53万
    • 财政年份:
      2001
    • 负责人:
      MORIWAKI Hisataka
    • 依托单位: